Availability and quality of data on pharmaceutical benefit financing components of health care system in United States, United Kingdom, Denmark, Germany, Italy and Poland

Authors

  • Tomasz Hermanowski
  • Sylwia I. Szafraniec-Burylo
  • Urszula Cegłowska
  • Aleksandra Drozdowska
  • Dominika Duleba
  • Marta Kowalczyk
  • Aleksandra N. Krancberg
  • Chris L. Pashos
  • Andrzej Szczypior
  • Malgorzata Chmielewska
  • Marcin Czech

DOI:

https://doi.org/10.5334/ijic.1280

Keywords:

pharmaceutical benefit, United Kingdom, Denmark, Germany, Italy, Poland

Author Biographies

  • Tomasz Hermanowski
    PhD, Professor, Head of Department of Pharmacoeconomics; InterQuality Project Leader, Medical University of Warsaw, Poland
  • Sylwia I. Szafraniec-Burylo

    MD, PhD, Department -Centre for Monitoring and Analyses of Population Health Status and Health Care System, National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland

  • Urszula Cegłowska
    MSc, Medical University of Warsaw, Poland
  • Aleksandra Drozdowska
    MSc, Medical University of Warsaw, Poland
  • Dominika Duleba
    MSc, Medical University of Warsaw, Poland
  • Marta Kowalczyk
    MSc, Medical University of Warsaw, Poland
  • Aleksandra N. Krancberg
    MSc, Medical University of Warsaw, Poland
  • Chris L. Pashos
    PhD, United BioSource Corporation, Lexington, MA, USA
  • Andrzej Szczypior
    MSc, Sopharm, Warsaw, Poland
  • Malgorzata Chmielewska
    MSc, Medical University of Warsaw, Poland
  • Marcin Czech

    MD, PhD, Associate Professor, Department of Pharmacoeconomics, Medical University of Warsaw, Poland

Downloads

Published

2013-10-23

Issue

Section

Poster Abstracts